TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 73 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $667,995 | +82.1% | 17,714 | +83.2% | 0.00% | – |
| Q2 2023 | $366,783 | +56.1% | 9,670 | +23.1% | 0.00% | – |
| Q3 2022 | $235,000 | -63.1% | 7,854 | -55.4% | 0.00% | – |
| Q2 2022 | $636,000 | +63.9% | 17,597 | +96.4% | 0.00% | – |
| Q1 2022 | $388,000 | -5.4% | 8,962 | +9.6% | 0.00% | – |
| Q4 2021 | $410,000 | -27.4% | 8,174 | -7.9% | 0.00% | – |
| Q3 2021 | $565,000 | -48.7% | 8,876 | -41.9% | 0.00% | – |
| Q2 2021 | $1,101,000 | -15.1% | 15,287 | -13.0% | 0.00% | – |
| Q1 2021 | $1,297,000 | +24.7% | 17,581 | +24.1% | 0.00% | – |
| Q4 2020 | $1,040,000 | -2.3% | 14,164 | -27.0% | 0.00% | – |
| Q3 2020 | $1,065,000 | +1.7% | 19,415 | +23.3% | 0.00% | – |
| Q2 2020 | $1,047,000 | -36.5% | 15,747 | -41.6% | 0.00% | -100.0% |
| Q1 2020 | $1,649,000 | +48.4% | 26,946 | +113.3% | 0.00% | – |
| Q4 2019 | $1,111,000 | +41.5% | 12,633 | +21.5% | 0.00% | – |
| Q3 2019 | $785,000 | -30.8% | 10,399 | -21.7% | 0.00% | – |
| Q2 2019 | $1,134,000 | -44.5% | 13,280 | -29.8% | 0.00% | -100.0% |
| Q1 2019 | $2,044,000 | -12.3% | 18,907 | -31.3% | 0.00% | 0.0% |
| Q4 2018 | $2,330,000 | +6.8% | 27,534 | +24.0% | 0.00% | 0.0% |
| Q3 2018 | $2,182,000 | -32.3% | 22,199 | -20.3% | 0.00% | 0.0% |
| Q2 2018 | $3,222,000 | -1.4% | 27,848 | -15.9% | 0.00% | 0.0% |
| Q1 2018 | $3,269,000 | -45.0% | 33,104 | -41.7% | 0.00% | 0.0% |
| Q4 2017 | $5,945,000 | -57.6% | 56,775 | -54.4% | 0.00% | -66.7% |
| Q3 2017 | $14,028,000 | +19.2% | 124,488 | +18.5% | 0.00% | 0.0% |
| Q2 2017 | $11,773,000 | -8.8% | 105,065 | -5.1% | 0.00% | -25.0% |
| Q1 2017 | $12,910,000 | +8.0% | 110,700 | -2.5% | 0.00% | +33.3% |
| Q4 2016 | $11,951,000 | -73.4% | 113,518 | -72.1% | 0.00% | -78.6% |
| Q3 2016 | $44,953,000 | -33.9% | 406,777 | -12.9% | 0.01% | -36.4% |
| Q2 2016 | $67,989,000 | +162.8% | 466,960 | +158.5% | 0.02% | +144.4% |
| Q1 2016 | $25,875,000 | -19.4% | 180,631 | -13.1% | 0.01% | -10.0% |
| Q4 2015 | $32,119,000 | +277.0% | 207,823 | +248.5% | 0.01% | +233.3% |
| Q3 2015 | $8,520,000 | +24.8% | 59,628 | +25.5% | 0.00% | +50.0% |
| Q2 2015 | $6,826,000 | -19.7% | 47,506 | -21.2% | 0.00% | -33.3% |
| Q1 2015 | $8,504,000 | +40.6% | 60,296 | +47.7% | 0.00% | +50.0% |
| Q4 2014 | $6,048,000 | +58.2% | 40,815 | +64.3% | 0.00% | +100.0% |
| Q3 2014 | $3,823,000 | +120.0% | 24,846 | +100.5% | 0.00% | 0.0% |
| Q2 2014 | $1,738,000 | +693.6% | 12,394 | +529.5% | 0.00% | – |
| Q1 2014 | $219,000 | -24.2% | 1,969 | -32.5% | 0.00% | – |
| Q4 2013 | $289,000 | – | 2,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |